Search

You searched for "urologist"

902 results found

Cord compression in cancer

1 September 2016 | | URO - Urologic Oncology
This article will be of great interest to uro-oncologists. Vertebral metastasis occurs in 3-5% of all cancers (most commonly in prostate, breast and lung cancer). It can cause pain, vertebral collapse and cord compression. Data from the National Institute for...

Andrology (2016)

1 July 2016 | | URO - Andrology
Case 1 Image A. Image B. Who is the mythological figure depicted in image A and how does he relate to a urological emergency? Define priapism and list five causes. In the context of a patient presenting with priapism, what...

Urological trauma – part 2

1 November 2015 | | URO - Trauma & Emergency
Part 1 of this topic is available here. Case 1 A 29-year-old male was attacked and kicked in his left flank. He presented to the emergency department with left flank pain and frank haematuria. He remained haemodynamically stable. 1. What...

Management of recurrent cystitis

1 March 2016 | | URO - Infection, URO - Functional / Reconstructive Urology
Acute uncomplicated infective cystitis is most commonly seen in healthy women with a frequency of around 0.5-0.7 episodes per woman per year [1]. Around 10% of women report having had an episode of urinary tract infection (UTI) each year and...

Recent advances in the management of castration resistant prostate cancer

1 November 2017 | | URO - Urologic Oncology
Castrate resistant prostate cancer (CRPC) is defined by disease progression despite androgen-deprivation therapy lowering testosterone to castrate levels. It may present as a rise in serum levels of prostate specific antigen (PSA), progression of pre-existing disease, or the appearance of...

Birmingham Women’s Hospital praises image quality, system usability and ease of patient access of Ultimax-i

25 May 2023 | Company Profiles, Contracts & Distributors, Research & Development
Female fluoroscopy procedures including Hysterosalpingography (HSG) to assess uterine cavity and fallopian tubes, as well as video...

An overview of non-surgical treatment options for Peyronie’s disease

3 May 2022 |
Peyronie’s disease (PD) is a therapeutic challenge despite the availability of several non-surgical and surgical options. Very few of these options are supported by good quality evidence according to the current American and European guidelines [1-3]. The period of plaque...

The how, why and when of bladder washouts: a guide

23 November 2022 | | URO - Functional / Reconstructive Urology, URO - Infection
Bladder washouts are a treatment usually employed by the urology team, more often in an inpatient setting, and commonly indicated for haematuria with clot retention and catheter bypassing [1,2]. Bladder washout is a cornerstone of treatment in urology wards, yet...

The process of medical innovation – evolving trends and future perspectives

5 May 2021 | | URO - Technology
In 2018 the United Kingdom Government spending on healthcare totalled almost £166 billion. Of this approximately 65% was attributed to providing curative or rehabilitation therapy, with health-related long-term care and provision of goods accounting for 25%. The remaining was accredited...

Urological etymology

4 May 2023 | | URO - Technology
In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). I’ve always found the derivation of names fascinating. Anatomy lessons were made so...

Prostate artery embolisation

1 August 2016 | | URO - Functional / Reconstructive Urology, URO - Uroradiology
Introduction Benign prostatic hyperplasia (BPH), a common condition associated with ageing, affects 50% of those between the ages of 50 and 60 years, and as many as 90% of those older than 80 years. BPH is characterised by unregulated, benign...

Focal therapy for prostate cancer – ready for prime time?

1 November 2016 | | URO - Basic Science Research, URO - Urologic Oncology
The current therapeutic ratio for radical therapy in many men with localised prostate cancer is not ideal. For a significant side-effect profile, there seems to be a small survival benefit over a 10-15 year period. A strategy that might balance...